Memory T cells maintain protracted protection against malaria

Immunology Letters

Volumn 161, Issue 2, 2014, Pages 189-195

  Krzych, Urszula ^a   Zarling, Stasya ^a   Pichugin, Alexander ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

CD8T cells; Liver; Malaria; Memory T cells; Mouse model; Plasmodium

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; CYTOKINE; PARASITE ANTIGEN;

ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; IMMUNIZATION; INFECTION PREVENTION; LIVER CELL; MALARIA; MALARIA CONTROL; MEMORY T LYMPHOCYTE; NONHUMAN; PARASITE CLEARANCE; PARASITE DEVELOPMENT; PARASITEMIA; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SPOROZOITE; T LYMPHOCYTE ACTIVATION; ANIMAL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LIVER; METABOLISM; PARASITOLOGY; PLASMODIUM; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, PROTOZOAN; CYTOKINES; HUMANS; IMMUNOLOGIC MEMORY; LIVER; MALARIA; PARASITEMIA; PLASMODIUM; SPOROZOITES; T-LYMPHOCYTE SUBSETS;

EID: 84906790586     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.03.011     Document Type: Article

References (122)

1. Ahmed R., Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996, 272:54-60.
2. Langhorne J., Ndungu F.M., Sponaas A.M., Marsh K. Immunity to malaria: more questions than answers. Nat Immunol 2008, 9:725-732.
3. Abdulla S., Oberholzer R., Juma O., Kubhoja S., Machera F., Membi C., et al. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med 2008, 359:2533-2544.
4. Krzych U., Schwenk R., Guebre-Xabier M., Sun P., Palmer D., White K., et al. The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites. Immunol Rev 2000, 174:123-134.
5. Crispe I.N. Liver antigen-presenting cells. J Hepatol 2011, 54:357-365.
6. Plebanski M., Lee E.A., Hannan C.M., Flanagan K.L., Gilbert S.C., Gravenor M.B., et al. Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming. Nat Med 1999, 5:565-571.
7. Good M.F., Xu H., Wykes M., Engwerda C.R. Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu Rev Immunol 2005, 23:69-99.
8. Urban B.C., Ing R., Stevenson M.M. Early interactions between blood-stage plasmodium parasites and the immune system. Curr Top Microbiol Immunol 2005, 297:25-70.
9. Nussenzweig R.S., Vanderberg J., Most H., Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 1967, 216:160-162.
10. Nussenzweig R.S., Vanderberg J., Most H., Orton C. Immunity in simian malaria induced by irradiated sporozoites. J Parasitol 1970, 56:350-351.
11. Clyde D.F., Most H., McCarthy V.C., Vanderberg J.P. Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci 1973, 266:169-177.
12. Nardin E.H., Nussenzweig R.S. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu Rev Immunol 1993, 11:687-727.
13. Egan J.E., Hoffman S.L., Haynes J.D., Sadoff J.C., Schneider I., Grau G.E., et al. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am J Trop Med Hyg 1993, 49:166-173.
14. Nardin E.H., Herrington D.A., Davis J., Levine M., Stuber D., Takacs B., et al. Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer. Science 1989, 246:1603-1606.
15. Wizel B., Houghten R.A., Parker K.C., Coligan J.E., Church P., Gordon D.M., et al. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. J Exp Med 1995, 182:1435-1445.
16. Palmer D.R., Krzych U. Cellular and molecular requirements for the recall of IL-4-producing memory CD4(+)CD45RO(+)CD27(-) T cells during protection induced by attenuated Plasmodium falciparum sporozoites. Eur J Immunol 2002, 32:652-661.
17. Krzych U., Lyon J.A., Jareed T., Schneider I., Hollingdale M.R., Gordon D.M., et al. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. J Immunol 1995, 155:4072-4077.
18. Lumsden J.M., Schwenk R.J., Rein L.E., Moris P., Janssens M., Ofori-Anyinam O., et al. Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-alpha producing effector and central memory CD4T cells. PLoS One 2011, 6:e20775.
19. Malik A., Egan J.E., Houghten R.A., Sadoff J.C., Hoffman S.L. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci U S A 1991, 88:3300-3304.
20. Spring M., Murphy J., Nielsen R., Dowler M., Bennett J.W., Zarling S., et al. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers. Vaccine 2013, 31:4975-4983.
21. Berenzon D., Schwenk R.J., Letellier L., Guebre-Xabier M., Williams J., Krzych U. Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells. J Immunol 2003, 171:2024-2034.
22. Schofield L., Villaquiran J., Ferreira A., Schellekens H., Nussenzweig R., Nussenzweig V. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 1987, 330:664-666.
23. Weiss W.R., Sedegah M., Beaudoin R.L., Miller L.H., Good M.F.C.D8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci U S A 1988, 85:573-576.
24. Jobe O., Lumsden J., Mueller A.K., Williams J., Silva-Rivera H., Kappe S.H., et al. Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. J Infect Dis 2007, 196:599-607.
25. Mueller A.K., Deckert M., Heiss K., Goetz K., Matuschewski K., Schluter D. Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. Am J Pathol 2007, 171:107-115.
26. Tarun A.S., Dumpit R.F., Camargo N., Labaied M., Liu P., Takagi A., et al. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis 2007, 196:608-616.
27. Trimnell A., Takagi A., Gupta M., Richie T.L., Kappe S.H., Wang R. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes. J Immunol 2009, 183:5870-5878.
28. Nganou-Makamdop K., van Gemert G.J., Arens T., Hermsen C.C., Sauerwein R.W. Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNgamma responses of hepatic CD8+ memory T cells. PLoS One 2012, 7:e36508.
29. Seder R.A., Chang L.J., Enama M.E., Zephir K.L., Sarwar U.N., Gordon I.J., et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 2013, 341:1359-1365.
30. Bejon P., Mwacharo J., Kai O., Todryk S., Keating S., Lowe B., et al. The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. J Immunol 2007, 179:4193-4201.
31. Seguin M.C., Klotz F.W., Schneider I., Weir J.P., Goodbary M., Slayter M., et al. Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. J Exp Med 1994, 180:353-358.
32. Cockburn I.A., Amino R., Kelemen R.K., Kuo S.C., Tse S.W., Radtke A., et al. In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages. Proc Natl Acad Sci U S A 2013, 110:9090-9095.
33. Cockburn I.A., Tse S.W., Zavala F.C.D8+ T cells eliminate liver stage Plasmodium parasites without detectable bystander effect. Infect Immun 2014.
34. Reyes-Sandoval A., Wyllie D.H., Bauza K., Milicic A., Forbes E.K., Rollier C.S., et al. CD8+ T effector memory cells protect against liver-stage malaria. J Immunol 2011, 187:1347-1357.
35. Hill A.V., Allsopp C.E., Kwiatkowski D., Anstey N.M., Twumasi P., Rowe P.A., et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991, 352:595-600.
36. Sturm A., Amino R., van de Sand C., Regen T., Retzlaff S., Rennenberg A., et al. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 2006, 313:1287-1290.
37. Baer K., Klotz C., Kappe S.H., Schnieder T., Frevert U. Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog 2007, 3:e171.
38. Tarun A.S., Baer K., Dumpit R.F., Gray S., Lejarcegui N., Frevert U., et al. Quantitative isolation and in vivo imaging of malaria parasite liver stages. Int J Parasitol 2006, 36:1283-1293.
39. Ishino T., Chinzei Y., Yuda M. A Plasmodium sporozoite protein with a membrane attack complex domain is required for breaching the liver sinusoidal cell layer prior to hepatocyte infection. Cell Microbiol 2005, 7:199-208.
40. Kariu T., Ishino T., Yano K., Chinzei Y., CelT.O.S.Yuda M. a novel malarial protein that mediates transmission to mosquito and vertebrate hosts. Mol Microbiol 2006, 59:1369-1379.
41. Talman A.M., Lacroix C., Marques S.R., Blagborough A.M., Carzaniga R., Menard R., et al. PbGEST mediates malaria transmission to both mosquito and vertebrate host. Mol Microbiol 2011, 82:462-474.
42. Fidock D.A., Pasquetto V., Gras H., Badell E., Eling W., Ballou W.R., et al. Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen. Eur J Immunol 1997, 27:2502-2513.
43. Frevert U. Malaria sporozoite-hepatocyte interactions. Exp Parasitol 1994, 79:206-210.
44. Robson K.J., Frevert U., Reckmann I., Cowan G., Beier J., Scragg I.G., et al. Thrombospondin-related adhesive protein (TRAP) of Plasmodium falciparum: expression during sporozoite ontogeny and binding to human hepatocytes. EMBO J 1995, 14:3883-3894.
45. Rogers W.O., Malik A., Mellouk S., Nakamura K., Rogers M.D., Szarfman A., et al. Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci U S A 1992, 89:9176-9180.
46. Hoffman S.L., Goh L.M., Luke T.C., Schneider I., Le T.P., Doolan D.L., et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002, 185:1155-1164.
47. Schmidt N.W., Butler N.S., Badovinac V.P., Harty J.T. Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites. PLoS Pathog 2010, 6:e1000998.
48. Hafalla J.C., Bauza K., Friesen J., Gonzalez-Aseguinolaza G., Hill A.V., Matuschewski K. Identification of targets of CD8(+) T cell responses to malaria liver stages by genome-wide epitope profiling. PLoS Pathog 2013, 9:e1003303.
49. Mueller A.K., Camargo N., Kaiser K., Andorfer C., Frevert U., Matuschewski K., et al. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci U S A 2005, 102:3022-3027.
50. Prudencio M., Rodriguez A., Mota M.M. The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol 2006, 4:849-856.
51. Bucci K., Kastens W., Hollingdale M.R., Shankar A., Alpers M.P., King C.L., et al. Influence of age and HLA type on interferon-gamma (IFN-gamma) responses to a naturally occurring polymorphic epitope of Plasmodium falciparum liver stage antigen-1 (LSA-1). Clin Exp Immunol 2000, 122:94-100.
52. Fidock D.A., Gras-Masse H., Lepers J.P., Brahimi K., Benmohamed L., Mellouk S., et al. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J Immunol 1994, 153:190-204.
53. Speake C., Duffy P.E. Antigens for pre-erythrocytic malaria vaccines: building on success. Parasite Immunol 2009, 31:539-546.
54. Holder A.A. Preventing merozoite invasion of erythrocytes. Malaria vaccine development: a multi-immune response approach 1996, 77-92. ASM Press, Washington, DC. S.L. Hoffman (Ed.).
55. Achtman A.H., Stephens R., Cadman E.T., Harrison V., Langhorne J. Malaria-specific antibody responses and parasite persistence after infection of mice with Plasmodium chabaudi chabaudi. Parasite Immunol 2007, 29:435-444.
56. Stephens R., Albano F.R., Quin S., Pascal B.J., Harrison V., Stockinger B., et al. Malaria-specific transgenic CD4(+) T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. Blood 2005, 106:1676-1684.
57. Jenne C.N., Kubes P. Immune surveillance by the liver. Nat Immunol 2013, 14:996-1006.
58. Lau A.H., de Creus A., Lu L., Thomson A.W. Liver tolerance mediated by antigen presenting cells: fact or fiction. Gut 2003, 52:1075-1078.
59. Knolle P.A., Germann T., Treichel U., Uhrig A., Schmitt E., Hegenbarth S., et al. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J Immunol 1999, 162:1401-1407.
60. Crispe I.N., Giannandrea M., Klein I., John B., Sampson B., Wuensch S. Cellular and molecular mechanisms of liver tolerance. Immunol Rev 2006, 213:101-118.
61. Steers N., Schwenk R., Bacon D.J., Berenzon D., Williams J., Krzych U. The immune status of Kupffer cells profoundly influences their responses to infectious Plasmodium berghei sporozoites. Eur J Immunol 2005, 35:2335-2346.
62. Frevert U., Nacer A., Cabrera M., Movila A., Leberl M. Imaging Plasmodium immunobiology in the liver, brain, and lung. Parasitol Int 2014, 63:171-186.
63. Tavares J., Formaglio P., Thiberge S., Mordelet E., Van Rooijen N., Medvinsky A., et al. Role of host cell traversal by the malaria sporozoite during liver infection. J Exp Med 2013, 210:905-915.
64. Krzych U. Malaria and the liver: tolerance and immunity to attenuated Plasmodia sporozoites. T lymphocytes in the liver: immunobiology, pathology and host defense 1999, 163-195. Wiley-Liss, New York. I.N. Crispe (Ed.).
65. Hollingdale M.R., Krzych U. Immune responses to liver-stage parasites: implications for vaccine development. Chem Immunol 2002, 80:97-124.
66. Zechini B., Cordier L., Ngonseu E., D'Alessandro U., Wery M., Chatterjee S. Plasmodium berghei development in irradiated sporozoite-immunized C57BL6 mice. Parasitology 1999, 118(Pt 4):335-338.
67. Scheller L.F., Azad A.F. Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. Proc Natl Acad Sci U S A 1995, 92:4066-4068.
68. Pradel G., Frevert U. Malaria sporozoites actively enter and pass through rat Kupffer cells prior to hepatocyte invasion. Hepatology 2001, 33:1154-1165.
69. Silvie O. A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J Biol Chem 2004, 279:9490-9496.
70. Zarling S., Berenzon D., Dalai S., Liepinsh D., Steers N., Krzych U. The survival of memory CD8 T cells that is mediated by IL-15 correlates with sustained protection against malaria. J Immunol 2013, 190:5128-5141.
71. Khan S., van den Broek M., Schwarz K., de Giuli R., Diener P.A., Groettrup M. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J Immunol 2001, 167:6859-6868.
72. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994, 12:991-1045.
73. White K.L., Snyder H.L., Krzych U. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. J Immunol 1996, 156:3374-3381.
74. Krzych U., Schwenk J. The dissection of CD8 T cells during liver-stage infection. Curr Top Microbiol Immunol 2005, 297:1-24.
75. Chakravarty S., Cockburn I.A., Kuk S., Overstreet M.G., Sacci J.B., Zavala F.C.D8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat Med 2007, 13:1035-1041.
76. Cabrera M., Pewe L.L., Harty J.T., Frevert U. In vivo CD8+ T cell dynamics in the liver of Plasmodium yoelii immunized and infected mice. PloS one 2013, 8:e70842.
77. Doolan D.L., Southwood S., Freilich D.A., Sidney J., Graber N.L., Shatney L., et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci U S A 2003, 100:9952-9957.
78. Aly A.S., Lindner S.E., MacKellar D.C., Peng X., Kappe S.H. SAP1 is a critical post-transcriptional regulator of infectivity in malaria parasite sporozoite stages. Mol Microbiol 2011, 79:929-939.
79. Vaughan A.M., O'Neill M.T., Tarun A.S., Camargo N., Phuong T.M., Aly A.S., et al. Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell Microbiol 2009, 11:506-520.
80. Butler N.S., Schmidt N.W., Vaughan A.M., Aly A.S., Kappe S.H., Harty J.T. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe 2011, 9:451-462.
81. Jobe O., Donofrio G., Sun G., Liepinsh D., Schwenk R., Krzych U. Immunization with radiation-attenuated Plasmodium berghei sporozoites induces liver cCD8alpha+DC that activate CD8+T cells against liver-stage malaria. PLoS One 2009, 4:e5075.
82. Cockburn I.A., Tse S.W., Radtke A.J., Srinivasan P., Chen Y.C., Sinnis P., et al. Dendritic cells and hepatocytes use distinct pathways to process protective antigen from plasmodium in vivo. PLoS Pathog 2011, 7:e1001318.
83. Guebre-Xabier M., Schwenk R., Krzych U. Memory phenotype CD8(+) T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium berghei sporozoites. Eur J Immunol 1999, 29:3978-3986.
84. Krzych U., Dalai S., Ehrler L., Jobe O., Egner L. Infectious challenge of Plasmodium berghei γ-spz immunized mice rescues effector CD8+ T cells, thus assuring protracted protection. J Immunol 2010, 184:52.59.
85. Doolan D.L., Hoffman S.L. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. J Immunol 1999, 163:884-892.
86. Klotz F.W., Scheller L.F., Seguin M.C., Kumar N., Marletta M.A., Green S.J., et al. Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites. J Immunol 1995, 154:3391-3395.
87. Tsuji M., Miyahira Y., Nussenzweig R.S., Aguet M., Reichel M., Zavala F. Development of antimalaria immunity in mice lacking IFN-gamma receptor. J Immunol 1995, 154:5338-5344.
88. Schmidt N.W., Podyminogin R.L., Butler N.S., Badovinac V.P., Tucker B.J., Bahjat K.S., et al. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc Natl Acad Sci U S A 2008, 105:14017-14022.
89. Badovinac V.P., Porter B.B., Harty J.T. Programmed contraction of CD8(+) T cells after infection. Nat Immunol 2002, 3:619-626.
90. Butler N.S., Vaughan A.M., Harty J.T., Kappe S.H. Whole parasite vaccination approaches for prevention of malaria infection. Trends Immunol 2012, 33:247-254.
91. Judge A.D., Zhang X., Fujii H., Surh C.D., Sprent J. Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells. J Exp Med 2002, 196:935-946.
92. Kaech S.M., Wherry E.J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002, 2:251-262.
93. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
94. Wherry E.J., Teichgraber V., Becker T.C., Masopust D., Kaech S.M., Antia R., et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003, 4:225-234.
95. De Jong R., Brouwer M., Hooibrink B., Van der Pouw-Kraan T., Miedema F., Van Lier R.A. The CD27- subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur J Immunol 1992, 22:993-999.
96. Morimoto C., Schlossman S.F. P. Rambotti lecture. Human naive and memory T cells revisited: new markers (CD31 and CD27) that help define CD4+ T cell subsets. Clin Exp Rheumatol 1993, 11:241-247.
97. Hintzen R.Q., Lens S.M., Lammers K., Kuiper H., Beckmann M.P., van Lier R.A. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J Immunol 1995, 154:2612-2623.
98. Joshi N.S., Cui W., Dominguez C.X., Chen J.H., Hand T.W., Kaech S.M. Increased numbers of preexisting memory CD8 T cells and decreased T-bet expression can restrain terminal differentiation of secondary effector and memory CD8 T cells. J Immunol 2011, 187:4068-4076.
99. Ciocca M.L., Barnett B.E., Burkhardt J.K., Chang J.T., Reiner S.L. Cutting edge: asymmetric memory T cell division in response to rechallenge. J Immunol 2012, 188:4145-4148.
100. D'Souza W.N., Hedrick S.M. Cutting edge: latecomer CD8 T cells are imprinted with a unique differentiation program. J Immunol 2006, 177:777-781.
101. Obar J.J., Lefrancois L. Early signals during CD8 T cell priming regulate the generation of central memory cells. J Immunol 2010, 185:263-272.
102. Gray D., Matzinger P. T cell memory is short-lived in the absence of antigen. J Exp Med 1991, 174:969-974.
103. Jelley-Gibbs D.M., Brown D.M., Dibble J.P., Haynes L., Eaton S.M., Swain S.L. Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation. J Exp Med 2005, 202:697-706.
104. Murali-Krishna K., Lau L.L., Sambhara S., Lemonnier F., Altman J., Ahmed R. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 1999, 286:1377-1381.
105. Zammit D.J., Turner D.L., Klonowski K.D., Lefrancois L., Cauley L.S. Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity 2006, 24:439-449.
106. Cockburn I.A., Chen Y.C., Overstreet M.G., Lees J.R., van Rooijen N., Farber D.L., et al. Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites. PLoS Pathog 2010, 6:e1000877.
107. Hafalla J.C., Sano G., Carvalho L.H., Morrot A., Zavala F. Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages. Proc Natl Acad Sci U S A 2002, 99:11819-11824.
108. Lau L.L., Jamieson B.D., Somasundaram T., Ahmed R. Cytotoxic T-cell memory without antigen. Nature 1994, 369:648-652.
109. Martin D.L., Antigen-specific Tarleton R.L. T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection. J Immunol 2005, 174:1594-1601.
110. Zinkernagel R.M., Bachmann M.F., Kundig T.M., Oehen S., Pirchet H., Hengartner H. On immunological memory. Annu Rev Immunol 1996, 14:333-367.
111. Gagnon E., Duclos S., Rondeau C., Chevet E., Cameron P.H., Steele-Mortimer O., et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 2002, 110:119-131.
112. Goldszmid R.S., Coppens I., Lev A., Caspar P., Mellman I., Sher A. Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells. J Exp Med 2009, 206:399-410.
113. Ku C.C., Murakami M., Sakamoto A., Kappler J., Marrack P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 2000, 288:675-678.
114. Li X.C., Demirci G., Ferrari-Lacraz S., Groves C., Coyle A., Malek T.R., et al. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med 2001, 7:114-118.
115. Sprent J., Surh C.D. T cell memory. Annu Rev Immunol 2002, 20:551-579.
116. Waldmann T.A., Dubois S., Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 2001, 14:105-110.
117. Schmidt N.W., Butler N.S., Harty J.T. Plasmodium-host interactions directly influence the threshold of memory CD8 T cells required for protective immunity. J Immunol 2011, 186:5873-5884.
118. Mattei F., Schiavoni G., Belardelli F., Tough D.F. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol 2001, 167:1179-1187.
119. McGill J., Van Rooijen N., Legge K.L. IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection. J Exp Med 2010, 207:521-534.
120. Dubois S., Mariner J., Waldmann T.A., Tagaya Y. IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 2002, 17:537-547.
121. Krzych U., Dalai S., Zarling S., Pichugin A. Memory CD8 T cells specific for plasmodia liver-stage antigens maintain protracted protection against malaria. Front Immunol 2012, 3:370.
122. Kokaji A.I., Hockley D.L., Kane K.P. IL-15 transpresentation augments CD8+ T cell activation and is required for optimal recall responses by central memory CD8+ T cells. J Immunol 2008, 180:4391-4401.